• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Exploring the application of stem cell technology in treating sensorineural hearing loss.探索干细胞技术在治疗感音神经性听力损失中的应用。
Am J Stem Cells. 2024 Aug 25;13(4):212-221. doi: 10.62347/AEIV5813. eCollection 2024.
2
Perspectives for the treatment of sensorineural hearing loss by cellular regeneration of the inner ear.内耳细胞再生治疗感音神经性听力损失的前景。
Acta Otorrinolaringol Esp. 2015 Sep-Oct;66(5):286-95. doi: 10.1016/j.otorri.2014.07.009. Epub 2014 Nov 20.
3
Differentiation and transplantation of human induced pluripotent stem cell-derived otic epithelial progenitors in mouse cochlea.人诱导多能干细胞源性耳上皮祖细胞在小鼠耳蜗中的分化和移植。
Stem Cell Res Ther. 2018 Aug 29;9(1):230. doi: 10.1186/s13287-018-0967-1.
4
Differentiation capacity of dental pulp stem cell into inner ear hair cell using an in vitro assay: a preliminary step toward treating sensorineural hearing loss.牙髓干细胞体外向内耳毛细胞分化能力的研究:治疗感音神经性聋的初步尝试。
Eur Arch Otorhinolaryngol. 2022 Apr;279(4):1805-1812. doi: 10.1007/s00405-021-06864-9. Epub 2021 May 19.
5
Current development of patient-specific induced pluripotent stem cells harbouring mitochondrial gene mutations and their applications in the treatment of sensorineural hearing loss.携带有线粒体基因突变的患者特异性诱导多能干细胞的最新发展及其在治疗感觉神经性耳聋中的应用。
Hear Res. 2023 Mar 1;429:108689. doi: 10.1016/j.heares.2023.108689. Epub 2023 Jan 5.
6
Stem cell therapy for the inner ear: recent advances and future directions.内耳的干细胞治疗:最新进展与未来方向。
Trends Amplif. 2012 Mar;16(1):4-18. doi: 10.1177/1084713812440336. Epub 2012 Apr 17.
7
Regeneration of Hair Cells: Making Sense of All the Noise.毛细胞再生:解读所有纷扰
Pharmaceuticals (Basel). 2011 Jun 1;4(6):848-879. doi: 10.3390/ph4060848.
8
Mammalian auditory hair cell regeneration/repair and protection: a review and future directions.哺乳动物听觉毛细胞的再生/修复与保护:综述及未来方向
Ear Nose Throat J. 1998 Apr;77(4):276, 280, 282-5.
9
[Strategies for a regenerative therapy of hearing loss. German version].[听力损失再生疗法的策略。德文版]
HNO. 2018 Mar;66(3):179-187. doi: 10.1007/s00106-017-0466-1.
10
A human induced pluripotent stem cell-based modular platform to challenge sensorineural hearing loss.基于人诱导多能干细胞的模块化平台,用于挑战感觉神经性听力损失。
Stem Cells. 2021 Jun;39(6):697-706. doi: 10.1002/stem.3346. Epub 2021 Feb 8.

本文引用的文献

1
Experimental drugs for the prevention or treatment of sensorineural hearing loss.用于预防或治疗感音神经性听力损失的实验性药物。
Expert Opin Investig Drugs. 2023 Jul-Dec;32(7):643-654. doi: 10.1080/13543784.2023.2242253.
2
The NLRP3 inflammasome as a target for sensorineural hearing loss.NLRP3炎性小体作为感音神经性听力损失的一个靶点。
Clin Immunol. 2023 Apr;249:109287. doi: 10.1016/j.clim.2023.109287. Epub 2023 Mar 11.
3
Hearing Recovery Induced by DNA Demethylation in a Chemically Deafened Adult Mouse Model.化学性致聋成年小鼠模型中DNA去甲基化诱导的听力恢复
Front Cell Neurosci. 2022 Feb 17;16:792089. doi: 10.3389/fncel.2022.792089. eCollection 2022.
4
Small activating RNA activation of ATOH1 promotes regeneration of human inner ear hair cells.小分子激活 RNA 激活 ATOH1 促进人内耳毛细胞再生。
Bioengineered. 2022 Mar;13(3):6729-6739. doi: 10.1080/21655979.2022.2045835.
5
Global return on investment and cost-effectiveness of WHO's HEAR interventions for hearing loss: a modelling study.世卫组织听力损失干预措施的全球投资回报率和成本效益:建模研究。
Lancet Glob Health. 2022 Jan;10(1):e52-e62. doi: 10.1016/S2214-109X(21)00447-2.
6
Selective ablation of cochlear hair cells promotes engraftment of human embryonic stem cell-derived progenitors in the mouse organ of Corti.选择性消融耳蜗毛细胞促进人胚胎干细胞来源的祖细胞在小鼠耳蜗中的植入。
Stem Cell Res Ther. 2021 Jun 19;12(1):352. doi: 10.1186/s13287-021-02403-9.
7
Advancements in Stem Cell Technology and Organoids for the Restoration of Sensorineural Hearing Loss.干细胞技术和类器官在感音神经性听力损失修复中的进展。
J Am Acad Audiol. 2021 Nov;32(10):636-645. doi: 10.1055/s-0041-1728677. Epub 2021 May 25.
8
Development of ebselen for the treatment of sensorineural hearing loss and tinnitus.用于治疗感音神经性听力损失和耳鸣的依布硒啉的研发。
Hear Res. 2022 Jan;413:108209. doi: 10.1016/j.heares.2021.108209. Epub 2021 Feb 19.
9
A human induced pluripotent stem cell-based modular platform to challenge sensorineural hearing loss.基于人诱导多能干细胞的模块化平台,用于挑战感觉神经性听力损失。
Stem Cells. 2021 Jun;39(6):697-706. doi: 10.1002/stem.3346. Epub 2021 Feb 8.
10
Therapeutic Application of Mesenchymal Stem Cells for Cochlear Regeneration.间质干细胞在耳蜗再生中的治疗应用。
In Vivo. 2021 Jan-Feb;35(1):13-22. doi: 10.21873/invivo.12227.

探索干细胞技术在治疗感音神经性听力损失中的应用。

Exploring the application of stem cell technology in treating sensorineural hearing loss.

作者信息

Li Min, Ma Rongyue, Li Qing, Guo Min

机构信息

Otorhinolaryngology Department, First Affiliated Hospital of Kunming Medical University Kunming, Yunnan, China.

Nephrology Department, First Affiliated Hospital of Kunming Medical University Kunming, Yunnan, China.

出版信息

Am J Stem Cells. 2024 Aug 25;13(4):212-221. doi: 10.62347/AEIV5813. eCollection 2024.

DOI:10.62347/AEIV5813
PMID:39308766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11411250/
Abstract

Sensorineural deafness mainly occurs due to damage to hair cells, and advances in stem cell technology, especially the application of induced pluripotent stem cells (iPSCs) and adult stem cells, provides new possibilities for hair cell regeneration. This review describes the basic knowledge of stem cells and their important applications in regenerative medicine, as well as recent progress in stem cell research in the field of hair cell regeneration, especially the induced differentiation of hair-like cells. At the same time, we also point out the challenges facing current research, including differentiation efficiency, cell stability issues, and treatment safety and long-term efficacy considerations. Finally, we look forward to the direction of future research, and emphasize the importance of the cell differentiation mechanism, simulation of the inner ear microenvironment, safety assessment, and personalized treatment strategies. In conclusion, despite many challenges, stem cell technology has shown great potential in the field of hearing research and is expected to bring revolutionary treatment options for patients with sensorineural hearing loss in the future.

摘要

感音神经性耳聋主要是由于毛细胞受损引起的,而干细胞技术的进步,特别是诱导多能干细胞(iPSC)和成体干细胞的应用,为毛细胞再生提供了新的可能性。本综述介绍了干细胞的基础知识及其在再生医学中的重要应用,以及毛细胞再生领域干细胞研究的最新进展,特别是类毛细胞的诱导分化。同时,我们也指出了当前研究面临的挑战,包括分化效率、细胞稳定性问题以及治疗安全性和长期疗效考量。最后,我们展望了未来研究的方向,并强调了细胞分化机制、内耳微环境模拟、安全性评估和个性化治疗策略的重要性。总之,尽管面临诸多挑战,干细胞技术在听力研究领域已展现出巨大潜力,有望在未来为感音神经性听力损失患者带来革命性的治疗选择。